Rennova Health, Inc. (NASDAQ:RNVA) belonging to the Medical sector has surged 0.84% and closed its last trading session at $0.08.
The company reported its EPS on 11/14/2016. Currently, the stock has a 1 Year Price Target of $18.5.
The consensus recommendation, according to Zacks Investment research, is 3. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 3 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 3 and 3 respectively.
Rennova Health, Inc. on 11/14/2016 reported its EPS as $-0.9 with the analysts projecting the EPS of the stock as $-1. The company beat the analyst EPS Estimate with the difference of $0.1. This shows a surprise factor of 10%.
Insider Trades for Rennova Health, Inc. show that the latest trade was made on 20 Sep 2016 where Epizon, Ltd., the Beneficial Owner of More than 10% Class completed a transaction type “Buy” in which 1146789 shares were traded at a price of $0.
1 analysts projected Price Targets for Rennova Health, Inc.. The analysts believe that the company stock price could grow as high as $18.5. The Low Price target projection by analysts is $18.5 and the Mean Price Target is $18.5.
Rennova Health, Inc. (NASDAQ:RNVA) has the market capitalization of $4.7 Million. The company rocked its 52-Week High of $1.16 on Jun 8, 2016 and touched its 52-Week Low of $0.08 on Jan 10, 2017. The stock has Return on Assets (ROA) of 0 percent. Return on Equity (ROE) stands at 0% and Return on Investment (ROI) of -334.8 percent.
The stock is currently showing YTD performance of 0.84 Percent. The company has Beta Value of -0.49 and ATR value of 0.02. The Weekly and Monthly Volatility stands at 10.70% and 19.54%.
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company’s solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.